对多化合物作为自然启发的蛋白酶体抑制剂的新见解
Emanuela Marchese1, Maria Eugenia Gallo Cantafio2, Francesca Alessandra Ambrosio2
1Dipartimento di Scienze della Salute, Università "Magna Græcia" di Catanzaro, Campus "S. Venuta", 88100 Catanzaro, Italy.
Pharmaceuticals (Basel, Switzerland)
|December 23, 2023
概括
像hesperidin和diosmin这样的多醇显示出作为抗癌剂的潜力. 这些天然化合物抑制蛋白酶体活性,为多发性骨髓瘤提供新的治疗策略.
科学领域:
- 自然产品化学 自然产品化学
- 分子药理学分子药理学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 聚是植物衍生化合物,具有多种生物活性,包括抗癌作用.
- 蛋白酶体是多发性骨髓瘤等癌症中验证的治疗点.
- 了解多作用的新机制对于药物开发至关重要.
研究的目的:
- 确定针对蛋白酶体的多的新型作用机制.
- 为了选FDA批准的多基分子,以检测蛋白质酶抑制活性.
- 评估针对多发性骨髓瘤的已识别化合物的抗瘤潜力.
主要方法:
- 来自DrugBank数据库的86种FDA批准的多的基于结构的虚拟选.
- 评估理论的结合亲和力和与关键蛋白酶体残留物的相互作用.
- 在体外评估多发性髓瘤细胞系中的β5-蛋白酶抑制和抗瘤活性.
主要成果:
- 通过虚拟查,hesperidin和diosmin被确定为有前途的候选物.
- 这些化合物表现出抑制β5-蛋白酶体活性的能力.
- 赫斯佩里丁和迪奥斯明对敏感和耐药的多发性髓瘤细胞系表现出抗瘤作用.
结论:
- 赫斯佩里丁和迪奥斯是新型蛋白酶体抑制剂,具有治疗多发性骨髓瘤的潜力.
- 这些发现为开发基于多的新型癌症疗法提供了基础.
- 该研究强调了基于结构的虚拟查在识别天然产品中的毒品线索方面的实用性.
相关概念视频
The Proteasome
847
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
847
The Proteasome Structure
762
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
762
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K


